Price Alert

Johnson & Johnson (JNJ)

NYSE: JNJ · Real-Time Price · USD

177.84

1.59 (0.90%)

At close: Aug 19, 2025, 2:43 PM

Johnson & Johnson Income Statement

Financials in USD. Fiscal year is February - January.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 29, 2025	Mar 30, 2025	Dec 29, 2024	Sep 29, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Oct 1, 2023	Jul 2, 2023	Apr 2, 2023	Jan 1, 2023	Oct 2, 2022	Jul 3, 2022	Apr 3, 2022	Jan 2, 2022	Oct 3, 2021	Jul 4, 2021	Apr 4, 2021
Revenue	90.63B	89.33B	88.82B	87.7B	86.58B	85.65B	85.16B	87.47B	86.11B	88.62B	91.15B	92.25B	95.59B	94.88B	93.78B	91.45B	89.19B	84.21B
Cost of Revenue	29.08B	28.32B	27.47B	27.14B	26.78B	26.38B	26.55B	27.52B	27.09B	28.54B	29.45B	29.64B	30.72B	30.39B	29.86B	29.71B	29.44B	28.43B
Gross Profit	61.55B	61.01B	61.35B	60.55B	59.79B	59.27B	58.61B	59.95B	59.03B	60.07B	61.69B	62.6B	64.87B	64.49B	63.92B	61.73B	59.75B	55.79B
Operating Income	22.13B	22.07B	22.05B	22.82B	23.73B	23.44B	23.41B	22.71B	22.17B	22.29B	22.16B	22.73B	23.93B	23.82B	24.55B	24.24B	23.32B	21.12B
Interest Income	905M	1.3B	1.33B	1.41B	1.5B	1.43B	1.26B	1.15B	928M	666M	490M	249M	112M	60M	53M	53M	52M	59M
Pretax Income	27.35B	26.6B	16.69B	17.63B	19.5B	20.06B	15.06B	14.44B	14.39B	13.93B	21.07B	21.71B	20.39B	21.21B	22.78B	19.59B	20.14B	17.42B
Net Income	22.66B	21.81B	14.07B	14.68B	38.02B	38.48B	35.15B	34.62B	13.05B	12.72B	17.94B	19.16B	18.37B	19.83B	20.88B	17.88B	17.77B	15.12B
Selling & General & Admin	22.43B	22.02B	22.07B	21.33B	21.15B	20.66B	20.11B	22.01B	21.59B	22.52B	23.65B	23.89B	25.02B	25.07B	24.66B	23.46B	22.99B	21.91B
Research & Development	16.99B	16.91B	17.23B	16.41B	14.91B	15.17B	15.09B	15.23B	15.27B	15.27B	15.88B	15.98B	15.92B	15.61B	14.71B	14.03B	13.44B	12.76B
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	39.42B	38.94B	39.3B	37.74B	36.06B	35.84B	35.2B	37.24B	36.86B	37.79B	39.53B	39.87B	40.94B	40.67B	39.37B	37.49B	36.44B	34.67B
Interest Expense	582M	804M	755M	769M	768M	715M	772M	798M	657M	478M	276M	159M	128M	130M	183M	210M	234M	239M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	68.5B	67.26B	66.77B	64.88B	62.84B	62.21B	61.75B	64.76B	63.94B	66.33B	68.99B	69.52B	71.66B	71.06B	69.23B	67.2B	65.87B	63.1B
Income Tax Expense	4.69B	4.79B	2.62B	2.86B	3.12B	2.99B	1.74B	1.72B	1.68B	1.77B	3.28B	2.7B	2.02B	1.38B	1.9B	1.71B	2.37B	2.3B
Shares Outstanding (Basic)	2.42B	2.41B	2.41B	2.41B	2.41B	2.41B	2.41B	2.52B	2.6B	2.61B	2.61B	2.62B	2.63B	2.63B	2.63B	2.63B	2.63B	2.63B
Shares Outstanding (Diluted)	2.42B	2.42B	2.43B	2.43B	2.42B	2.43B	2.43B	2.55B	2.63B	2.61B	2.66B	2.66B	2.67B	2.67B	2.67B	2.67B	2.67B	2.67B
EPS (Basic)	9.41	9.07	5.85	6.10	15.30	15.33	13.95	13.62	5.00	4.85	6.84	7.29	6.98	7.53	7.92	6.78	6.74	5.74
EPS (Diluted)	9.35	8.99	5.79	6.05	15.15	15.18	13.81	13.47	4.94	4.78	6.74	7.18	6.87	7.42	7.81	6.69	6.65	5.66
EBITDA	33.4B	34.7B	24.78B	25.68B	27.54B	28.2B	23.32B	22.65B	22.32B	21.48B	28.32B	28.91B	27.68B	28.6B	30.35B	27.28B	27.86B	25.03B
EBIT	27.88B	27.41B	17.44B	18.39B	20.27B	20.78B	15.83B	15.23B	15.05B	14.4B	21.35B	21.87B	20.52B	21.34B	22.96B	19.8B	20.37B	17.66B
Depreciation & Amortization	5.51B	7.3B	7.34B	7.29B	7.27B	7.42B	7.49B	7.42B	7.27B	7.08B	6.97B	7.04B	7.17B	7.26B	7.39B	7.49B	7.49B	7.38B